GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biosenic (LTS:0R55) » Definitions » Future 3-5Y EPS without NRI Growth Rate

Biosenic (LTS:0R55) Future 3-5Y EPS without NRI Growth Rate : N/A (As of May. 04, 2025)


View and export this data going back to 2015. Start your Free Trial

What is Biosenic Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Biosenic's Future 3-5Y EPS without NRI Growth Rate is N/A.

Competitive Comparison of Biosenic's Future 3-5Y EPS without NRI Growth Rate

For the Biotechnology subindustry, Biosenic's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biosenic's Future 3-5Y EPS without NRI Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biosenic's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Biosenic's Future 3-5Y EPS without NRI Growth Rate falls into.


;
;

Biosenic  (LTS:0R55) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

Biosenic Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Biosenic's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Biosenic Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biosenic (LTS:0R55) » Definitions » Future 3-5Y EPS without NRI Growth Rate
Comparable Companies
XBRU:OXUR VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270 SMMT RPRX XKRX:196170 OCSE:GMAB INSM BMRN HKSE:02269 SHSE:603392 INCY
Traded in Other Exchanges
BT1:Germany BIOS:Belgium
Address
Rue Granbonpre 11, Batiment H (bte 24), Mont-St-Guibert, BEL, 1435
Website
https://www.biosenic.com
Biosenic is engaged in the development of cell therapy products for orthopaedics and bone diseases. The product pipeline of the company includes; ALLOB for treatment of delayed-union fractures, spinal fusion procedures and revision spinal fusion, and PREOB. In addition, the firm is also focused on conducting preclinical research on next-generation product candidates such as combined cell-matrix products for large bone defects and maxillofacial applications.

Biosenic Headlines

No Headlines